Adapting Management of Sarcomas in COVID-19: An Evidence-Based Review.

COVID-19 India Sarcoma Treatment guidelines

Journal

Indian journal of orthopaedics
ISSN: 0019-5413
Titre abrégé: Indian J Orthop
Pays: Switzerland
ID NLM: 0137736

Informations de publication

Date de publication:
May 2021
Historique:
received: 20 04 2020
accepted: 18 05 2020
pubmed: 25 8 2020
medline: 25 8 2020
entrez: 25 8 2020
Statut: epublish

Résumé

With the novel coronavirus disease (COVID-19) being declared a global pandemic by the World Health Organization, the Indian healthcare sector is at the forefront to deliver optimal care. Patients with cancer especially are at serious risk for increased chances of morbidity and mortality due to their immunocompromised state. Currently there is a paucity of definitive guidelines for the management of sarcomas during the pandemic in a resource-constrained and diverse population setting like India. Health care professionals from various specialties involved in the management of sarcomas have collaborated to discuss various aspects of evidence-based sarcoma management during the COVID-19 pandemic. This article provides structured recommendations for HCP to adapt to the situation, optimize treatment protocols with judicious use of all resources while providing evidence-based treatment for sarcoma patients.

Identifiants

pubmed: 32836361
doi: 10.1007/s43465-020-00143-1
pii: 143
pmc: PMC7261215
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1-13

Informations de copyright

© Indian Orthopaedics Association 2020.

Déclaration de conflit d'intérêts

Conflict of interestThe authors declare that they have no conflict of interest.

Références

Ann Oncol. 2020 Jul;31(7):965-966
pubmed: 32278878
Lancet Oncol. 2020 May;21(5):619-621
pubmed: 32220659
N Engl J Med. 2020 Feb 27;382(9):866
pubmed: 31986242
Nat Rev Clin Oncol. 2020 May;17(5):268-270
pubmed: 32242095
JAMA Intern Med. 2018 Jul 1;178(7):930-940
pubmed: 29802770
Lancet. 2012 May 19;379(9829):1879-86
pubmed: 22595799
Eur J Radiol. 2020 May;126:108961
pubmed: 32229322
CMAJ Open. 2013 Jan 24;1(1):E27-36
pubmed: 25077099
Clin Oncol (R Coll Radiol). 2014 Nov;26(11):722-9
pubmed: 24919857
J Clin Orthop Trauma. 2020 May-Jun;11(3):500-503
pubmed: 32292256
Ther Adv Med Oncol. 2017 Jun;9(6):415-429
pubmed: 28607580
Oncologist. 2020 Jun;25(6):e936-e945
pubmed: 32243668
J Clin Oncol. 1993 Jul;11(7):1269-75
pubmed: 8315424
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Ann Oncol. 2010 May;21(5):1130-1
pubmed: 20093352
Oncotarget. 2017 Jan 24;8(4):7068-7093
pubmed: 27732970
Radiology. 2020 Aug;296(2):E72-E78
pubmed: 32216717
Lancet Psychiatry. 2020 Apr;7(4):300-302
pubmed: 32085840
Anesth Pain Med. 2012 Spring;1(4):237-8
pubmed: 24904806
Am Soc Clin Oncol Educ Book. 2019 Jan;39:616-623
pubmed: 31099628
Pediatr Blood Cancer. 2018 Feb;65(2):
pubmed: 29077260
Sarcoma. 2011;2011:325189
pubmed: 22190862
Eur J Cancer. 2001 Jun;37(9):1096-103
pubmed: 11378339
Eur J Cancer. 2011 Nov;47(16):2431-45
pubmed: 21703851
Lancet Oncol. 2018 Aug;19(8):1061-1071
pubmed: 29941280
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):127-136
pubmed: 30593906
J Clin Oncol. 2012 Nov 20;30(33):4148-54
pubmed: 23091096
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Ann Oncol. 2012 Dec;23(12):3171-3179
pubmed: 22711763
Lancet Oncol. 2020 May;21(5):629-630
pubmed: 32247319
JAMA Oncol. 2017 Sep 01;3(9):1222-1227
pubmed: 28384657
Radiology. 2008 Mar;246(3):697-722
pubmed: 18195376
Pediatr Blood Cancer. 2019 Sep;66(9):e27811
pubmed: 31207063
Cancer Discov. 2020 Jun;10(6):755
pubmed: 32276930
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Swiss Med Wkly. 2020 Mar 24;150:w20233
pubmed: 32208494
BMJ. 2020 Mar 17;368:m1086
pubmed: 32184201
Clin Cancer Res. 2009 Feb 1;15(3):1096-104
pubmed: 19188185
Clin Transl Oncol. 2016 Sep;18(9):937-44
pubmed: 26742936
Chest. 2009 Jun;135(6):1665-1672
pubmed: 19497902
CMAJ. 2014 Apr 1;186(6):425-32
pubmed: 23857860
Lancet. 1997 Dec 6;350(9092):1647-54
pubmed: 9400508

Auteurs

Ashish Gulia (A)

Bone and Soft Tissue Services, Department of Surgical Oncology, Tata Memorial Hospital, and Homi Bhabha National Institure (HBNI), Mumbai, India.

Ramandeep Singh Arora (RS)

Paediatric Oncology, Max Super Speciality Hospital, New Delhi, India.

Pankaj Kumar Panda (PK)

Department of Clinical Research, Apollo Proton Cancer Centre, Chennai, India.

Anand Raja (A)

Department of Surgical Oncology, Cancer Institute (WIA), Adyar, Chennai, India.

Akshay Tiwari (A)

Musculoskeletal Oncology, Max Institute of Cancer Care, Saket, New Delhi, India.

Sameer Bakhshi (S)

Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Naveen Salins (N)

Department of Palliative Medicine and Supportive Care, Kasturba Medical College, MAHE, Manipal, India.

Vineeta Goel (V)

Radiation Oncology, Max Super Speciality Hospital, Shalimar Bagh, New Delhi, India.

Amit Janu (A)

Department of Radiology, Tata Memorial Hospital, and Homi Bhabha National Institure (HBNI), Mumbai, India.

Classifications MeSH